BRISTOL, Tenn., Jan. 4 /PRNewswire-FirstCall/ -- King Pharmaceuticals,
Inc. (NYSE: KG) will host a live webcast of its meeting with investors
scheduled for Thursday, January 5, 2006, at 12:15 p.m., E.S.T. at the Morgan
Stanley Pharmaceutical Conference at Morgan Stanley's Corporate Headquarters
in New York, New York. The Company expects topics of discussion to include
the Company's strategic plan for growth, an update on the status of ongoing
development projects, and other matters pertaining to King's business.
Interested persons may access the webcast on the King Pharmaceuticals home
page at http://www.kingpharm.com. After the event, a replay of the webcast
may be accessed through Thursday, January 19, 2006 at the same URL.
King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and acquisitions, of
novel branded prescription pharmaceutical products in attractive markets and
the strategic acquisition of branded products that can benefit from focused
promotion and marketing and product life-cycle management.
SOURCE King Pharmaceuticals, Inc.
 back to top
Related links:
http://www.kingpharm.com
Company News On-Call:
http://www.prnewswire.com/comp/120319.html
CONTACT:
James E. Green, Executive Vice President,
Corporate Affairs, +1-423-989-8125, or David E. Robinson, Sr.
Director, Corporate Affairs, +1-423-989-7045, both of King
Pharmaceuticals, Inc.
|
